Jonathan Govette: AI in Healthcare: Bridging the Gap Between Potential and Adoption
Jonathan Govette, Chief Executive Officer of Oatmeal Health, posted on LinkedIn, about recent paper by Kevin Wu et al., titled “Characterizing the Clinical Adoption of Medical AI Devices through U.S. Insurance Claims” published on NEJM.
Authors: Kevin Wu, Eric Wu, Brandon Theodorou, Weixin Liang, Christina Mack, Lucas Glass, Jimeng Sun, and James Zou
“AI has the potential to revolutionize healthcare, yet adoption lags due to challenges like validation, scalability, and monitoring. The NEJM AI article highlights the gaps: lack of standards, costly audits, and performance declines over time.
At Oatmeal Health, we’re tackling these issues head-on. Our AI-powered lung cancer screening platform outperforms leading models and ensures scalability across imaging datasets like X-rays and MRIs.
With robust post-deployment monitoring, we’re proving AI can deliver real-world impact.
It’s time to close the gap between AI’s potential and adoption. Let’s make healthcare innovation accessible and impactful.”
Jonathan Govette is the Chief Executive Officer of Oatmeal Health. In addition to his role at Oatmeal Health, Jonathan serves as an advisor at Plug and Play Tech Center, where he helps startups grow by connecting them with key industry partners and resources. He is also a mentor for Techstars, a global accelerator program that supports entrepreneurs in building successful businesses. Jonathan is also a member of the Digital Medicine Society (DiMe), where he collaborates with leaders in the field to drive forward the adoption of digital health solutions.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023